Stock NRX NUREXONE BIOLOGIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NurExone Biologic Inc.

Equities

NRX

CA67059R1091

Market Closed - Toronto S.E.
Other stock markets
 15:59:35 2024-07-05 EDT 		5-day change 1st Jan Change
0.7 CAD +1.45% Intraday chart for NurExone Biologic Inc. +6.06% +137.29%
06-28 NurExone Biologic Inc. Announces Pre-Clinical Study to Explore the Potential of NurExone's Exosome-Based Therapies in Regenerating Damaged Optic Nerves CI
05-29 NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NUREXONE BIOLOGIC INC. Stock NurExone Biologic Inc.
 34.49M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.34B -
LONZA GROUP AG Stock Lonza Group AG
 40.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.92B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.75B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.71B
  1. Stock Market
  2. Equities
  3. NRX Stock
  4. Charts NurExone Biologic Inc.
  5. Sector Chart